NCT01004224 · Interventional trial
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Overall registry status Completed
Phase 1
Conditions Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Advanced Solid Tumors With FGFR1 Amplication, Advanced Solid Tumors With FGFR2 Amplication, Advanced Solid Tumors With FGFR3 Mutation, Bladder Cancer With FGFR3 Mutation or Fusion, Squamous Lung Cancer With FGFR1 Amplification
Delaware Valley sites
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University Hospital Onc Dept · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory